Korean scientists have discovered ways to replicate pancreatic beta cells destroyed by type 1 diabetes, which is usually diagnosed in children, teens, and young adults.
Type 1 diabetes is a condition in which the patient’s immune system destroys insulin-making cells in their pancreas. These are called beta cells.
The research findings were published in the December issue of “Food Science & Nutrition,” a global journal on the list of Science Citation Index (SCI). The paper says that food-type treatment materials “Diabetes & Dietary (D&D)” have been found to be effective in treating diabetes. They lower blood sugar, increase C-peptide and insulin production, lowers GTT and ITT blood sugar, replicate destroyed pancreas beta cells, increase the amount and region of insulin production.
In particular, the report draws attention as it sheds light on the endogenous regeneration of destructed pancreatic beta bells.
D&D is a material developed by Lee Sam-goo, CEO of 239bio Inc. He studied three types of D&D -- D&D1, D&D2, and D&D3. A Korean university hospital accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) has discovered through pre-clinical trials that one or two D&D meals a day alone, without insulin injection, insulin pump or diabetes medication, can help regenerate destructed pancreatic beta cells.
Lee said, “Jaakko Kaprio of University of Helsinki, the world’s highest authority in the fields of diabetes, cardiovascular diseases, and dementia, has joined the global clinical trials for D&D,” adding that he has been invited by a foreign diabetes academy to make a presentation on the effectiveness of D&D.
Meanwhile, there are about 500 million diabetics worldwide, including 5 million in Korea, 130 million in China, 32 million in the United States, and 10 million in Japan. And patients with type 1 diabetes are known to reach 5 to 10 percent of the total diabetics.